In This Month’s GeoWire Gearing Up for The Starting Five Virtual Conference #4, And Reflecting on #3 Uncovering Two Micro-Cap Multibaggers Through Press Release Research: PSIX and CSBR [Case Studies] The Role of Politics and Macro Trends in Microcap Investing […]
We are adding a niche medical device company to our Run to One (R21) Model Portfolio. It is an under-the-radar growth story where management believes the company’s specialized products, rapid manufacturing capabilities, and disciplined financial execution give it a competitive edge in a traditionally slow-moving industry.
Decades of micro-cap research taught me that hidden details in press releases can reveal opportunities that result in outsized investment gains. To capitalize on this, my team and I developed a specialized platform that quickly prioritizes smaller-cap public company press releases so we can identify and act on critical insights ahead of the crowd— Two recent multibagger case studies of stocks on our Model Portfolios showcase this advantage
One of my goals at GeoInvesting, as well as at my new Substack, is to continue to highlight some of the best investors in the microcap space to help all of us generate alpha. Hand-picking these investors isn’t easy, but I think it’s what you expect us to do for you.
A recent development has positioned a little-known company for what could be a significant transformation.
With a new customer that has the potential to double the size of the business and improve margins, the company is entering a new market with broad growth opportunities.
However, we found commentary about additional new customer relationships that should be announced soon. This commentary was not that easy to find and is not in the company’s press releases.
It is particularly important for investors that don’t have enough time to perform the deep dive analysis necessary to run a concentrated strategy to expose themselves to a diversified portfolio of high-quality microcap stocks that can offer the alpha-rich returns other classes of market capitalization cannot always promise.
Fresh off our Live Open Forum reviewing December 2024, we are welcoming 2025 with continued optimism that microcaps will continue to perform well, especially in certain industries. While we didn’t do a full year review as part of the forum, a few days earlier I was able able to sit down with Bobby Kraft of the Plant Microcap Podcast for a focused MicroCap Year-End Review in which we dissected key developments in the microcap space over the past year.
We’re currently vetting a company in the defense industry that we believe may be uniquely positioned to benefit from the drone emergence by beginning to market existing technologies into the industry.
While it’s still too early for us to determine if this company will target the drone market, we know the company well, because it’s already part of our Coverage Universe. Our preliminary research indicates that their products could clearly be a good fit within the commercial/military drone industry ecosystem.